Cargando…
GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
Gastrin-releasing peptide receptor (GRPR) is differentially expressed on the surfaces of various diseased cells, including prostate and lung cancer. However, monitoring temporal and spatial expression of GRPR in vivo by clinical MRI is severely hampered by the lack of contrast agents with high relax...
Autores principales: | Pu, Fan, Qiao, Jingjuan, Xue, Shenghui, Yang, Hua, Patel, Anvi, Wei, Lixia, Hekmatyar, Khan, Salarian, Mani, Grossniklaus, Hans E., Liu, Zhi-Ren, Yang, Jenny J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649707/ https://www.ncbi.nlm.nih.gov/pubmed/26577829 http://dx.doi.org/10.1038/srep16214 |
Ejemplares similares
-
Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases
por: Tan, Shanshan, et al.
Publicado: (2020) -
Early detection and staging of chronic liver diseases with a protein MRI contrast agent
por: Salarian, Mani, et al.
Publicado: (2019) -
Early Detection and
Staging of Lung Fibrosis Enabled
by Collagen-Targeted MRI Protein Contrast Agent
por: Ibhagui, Oluwatosin Y., et al.
Publicado: (2023) -
HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent
por: Qiao, Jingjuan, et al.
Publicado: (2011) -
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
por: Mitran, Bogdan, et al.
Publicado: (2019)